-+ 0.00%
-+ 0.00%
-+ 0.00%

China Biotech Services signs cross-border BNCT clinical services cooperation pact with OncoCare

PUBT·09/02/2026 23:24:25
Listen to the news
China Biotech Services signs cross-border BNCT clinical services cooperation pact with OncoCare
  • China Biotech Services’ Pengbo (Hainan) BNCT Hospital signed a one-year cooperation agreement with Hong Kong oncology provider OncoCare on Sept. 2, 2026.
  • Partnership targets cross-border BNCT clinical services, two-way patient referrals, joint MDT consultations, post-treatment follow-up.
  • Model centers on offshore assessment, onshore treatment in Hainan’s Boao Lecheng pilot zone, offshore follow-up via OncoCare’s network.
  • OncoCare handles overseas screening, referral coordination, patient guidance, rehabilitation follow-up; the hospital delivers BNCT treatment, inpatient care, quality oversight.
  • Agreement aims to expand the hospital’s overseas BNCT patient pipeline, leveraging Tamarind Health’s regional oncology network.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260903-12317184), on September 02, 2026, and is solely responsible for the information contained therein.